Real-world effectiveness and safety of sofosbuvir plus daclatasvir with or without ribavirin for genotype 2 chronic hepatitis C in Taiwan.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the Formosan Medical Association = Taiwan yi zhi"
DOI: 10.1016/j.jfma.2018.09.016
Abstract: BACKGROUND AND PURPOSE Sofosbuvir (SOF) and daclatasvir (DCV) treatment achieves excellent efficacy and safety in treating chronic hepatitis C (CHC) with various genotypes. Real world experience of SOF/DCV regimen to treat genotype 2 CHC was… read more here.
Keywords: real world; ribavirin; sof dcv; safety ... See more keywords
A not so easy genotype—striking regional differences in SOF/RBV treatment responses in HCV GT2
Sign Up to like & getrecommendations! Published in 2017 at "Liver International"
DOI: 10.1111/liv.13447
Abstract: We report 111 SOFbased regimens (73 SOF+RBV and 38 SOF+DCV) prescribed, from February 2015 until February 2017, for 108 consecutive HCV GT2infected individuals (three subjects un‐ derwent a retreatment with SOF+DCV for 12 weeks after… read more here.
Keywords: treatment; sof dcv; sof rbv;
Sofosbuvir with daclatasvir and the outcomes of patients with COVID-19: a systematic review and meta-analysis with GRADE assessment.
Sign Up to like & getrecommendations! Published in 2022 at "Postgraduate medical journal"
DOI: 10.1136/postgradmedj-2021-140287
Abstract: PURPOSE This systematic review and meta-analysis aimed to evaluate the effect of sofosbuvir/daclatasvir (SOF/DCV) on mortality, the need for intensive care unit (ICU) admission or invasive mechanical ventilation (IMV) and clinical recovery in patients with… read more here.
Keywords: sof dcv; clinical recovery; meta analysis; mortality ... See more keywords
Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study
Sign Up to like & getrecommendations! Published in 2018 at "Virology Journal"
DOI: 10.1186/s12985-018-1066-8
Abstract: BackgroundChronic hepatitis C virus (HCV) genotype (GT) 3 infection with advanced liver disease has emerged as a challenging to treat by direct-acting antivirals (DAAs), but the efficacy of DAAs in Chinese HCV-GT3 patients is rarely… read more here.
Keywords: sof dcv; infection; sof; study ... See more keywords